alanine has been researched along with myricetin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
Cui, SX; Li, F; Li, WB; Qu, XJ; Song, ZY; Wang, F; Zhang, L | 1 |
Cui, SX; Hu, XT; Miao, RR; Qu, XJ; Wu, LJ; Yuan, WM; Zhan, S | 1 |
3 other study(ies) available for alanine and myricetin
Article | Year |
---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
M10, a novel derivative of Myricetin, prevents ulcerative colitis and colorectal tumor through attenuating robust endoplasmic reticulum stress.
Topics: Alanine; Animals; Anticarcinogenic Agents; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Disease Models, Animal; Endoplasmic Reticulum Stress; Flavonoids; Hydroxyquinolines; Inflammation; Inflammation Mediators; Interleukin-6; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2018 |
Myricetin and M10, a myricetin-3-O-β-d-lactose sodium salt, modify composition of gut microbiota in mice with ulcerative colitis.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Colitis, Ulcerative; Dextran Sulfate; Flavonoids; Gastrointestinal Microbiome; Hydroxyquinolines; Male; Mesalamine; Mice; Mice, Inbred C57BL; RNA, Bacterial | 2021 |